COT Register of Interests A - E

Direct employment.

Lecturer in Pharmacology and Physiology at the University of Aberdeen, since January 2023.

Consultancies and other fee-paid work.

None.

Shareholdings.

None.

Clubs, other organisations and advocacy groups.

Member at the British Toxicology Society, Since 2018.

Member at the British Pharmacology Society, since 2023.

Member at the American Society for Pharmacology and Experimental Therapeutics, since 2016

Other personal interests.

Visting Lecturer in Pharmacology and Toxicology at Newcastle University, since January 2023

Visting Lecturer in Pharmacology and Toxicology at Cairo University, since February 2022.

Fellowships.

None.

Indirect support.

None.

Trusteeships.

None.

Land and property.

None.

Other public appointments.

None.

Other non-personal interests.

None.

Direct employment.

Lecturer in Pharmacology at Newcastle University from September 2021 – January 2023.Research Assistant at the Complex Drug Delivery Project, Newcastle University (August 2020 – August 2021)

Associate Lecturer in Pharmacology and Toxicology at Cairo University from May 2012

Consultancies and other fee-paid work.

Shareholdings.

Clubs, other organisations and advocacy groups.

Other personal interests.

Fellowships.

Received a British Council scholarship to pursue a PhD at Newcastle University (2017–2021).

Indirect support.

None.

Trusteeships.

None.

Land and property.

None.

Other public appointments.

None.

Other non-personal interests.

Direct employment.

Edinburgh Napier University (2011-Current). 

Consultancies and other fee-paid work.

In my University role I was paid a small consultancy fee to undertake an interview with BBC Radio Scotland on measles virus in July 2025. 

Shareholdings.

None.

Clubs, other organisations and advocacy groups.

Chair – Chief Scientist Office Clinical Academic Fellowship Committee (non-remunerated role),

Chair – NHS Assure Grant Funding Panel (non-remunerated role),

Member of British Society of Immunology.

Other personal interests.

Co-Founder of an emerging Edinburgh Napier spinout entity (PlusPEP). Future commercial focus around the application of Sodium Butyrate and/or vitamin D for the treatment of rhinovirus infection in humans (International patent WO2021198691A1).

Grant holder and Principal Investigator, Interface Innovation Voucher, held with Mercel Ltd. “Algumer Enzyme Protection”.

External Examiner at the University of Birmingham for an MSc from September 2025. 

Fellowships.

Fellow of the Royal Society of Biology (current).

Indirect support.

None.

Trusteeships.

None.

Land and property.

None.

Other public appointments.

None.

Other non-personal interests.

None.

Direct employment.

United States Centers for Disease Control and Prevention (US Government Agency) (2009-2011),

University of Edinburgh (2005-2009),

Policy officer at the Health Department, Scottish Government (2004-2005).

Consultancies and other fee-paid work.

Expert Advisor, Dunedin Solutions Ltd (Nov 2023-2025) Unremunerated role. 

Shareholdings.

None.

Clubs, other organisations and advocacy groups.

None.

Other personal interests.

None.

Fellowships.

British Science Association Media Fellowship (2018), hosted by BBC Scotland.

Indirect support.

None.

Trusteeships.

None.

Land and property.

None.

Other public appointments.

None.

Other non-personal interests.

Direct employment.

University of Glasgow, School of Biodiversity, One Health and Veterinary Medicine, full-time. Since 2004

Consultancies and other fee-paid work.

None

Shareholdings.

None.

Clubs, other organisations and advocacy groups.

Trustee and board member of British Society for Neuroendocrinology (2013-present)

Treasurer of British Society for Neuroendocrinology (2019-present)..

Other personal interests.

Author of Scientific Impact Paper 37 “Chemical exposures during pregnancy: dealing with potential, but unproven, risks to child health” for Royal College of Obstetricians and Gynaecologists, 2013.

Co-Author of opinion paper “A new consensus on reconciling fire safety with environmental & health impacts of chemical flame retardants”. Environ Int. 2023 doi: 10.1016/j.envint.2023.107782

Co-Author of article. “Breast cancer risk and prevention in 2024: An overview from the Breast Cancer UK “- Breast Cancer Prevention Conference. Cancer Med. 2024 Sep;13(18):e70255.

Fellowships.

None. 

Indirect support.

Grants:

NIH R01 ES030374 2019-2025 “Transgenerational consequences of pre-conceptional and in utero exposure to real-life chemical mixtures on fertility and metabolic health” (2019-2025)

Trusteeships.

None.

Land and property.

None.

Other public appointments.

None.

Other non-personal interests.

Scientific Review Panel Breast Cancer UK (2017-2025)

Media Ambassador Society for Endocrinology (2018-2023)

Direct employment.

Consultancies and other fee-paid work.

Shareholdings.

Clubs, other organisations and advocacy groups.

Other personal interests.

Fellowships.

None.

Indirect support.

None.

Trusteeships.

None.

Land and property.

None.

Other public appointments.

None.

Other non-personal interests.

Direct employment.

Syngenta and its legacy companies Zeneca and ICI since 1980. Principal Science Advisor (Product Safety) since 2017

Consultancies and other fee-paid work.

Regulatory Science Associates – Leadership Consultant. Since 2018

Shareholdings.

AstraZeneca. Since 1999

Clubs, other organisations and advocacy groups.

Crop Life International, Crop Life Europe – Chair or Member of Human Health Expert Groups since 2002 (CLE) and 2017 (CLI)

European Centre for Ecotoxicology and Toxicology (ECETOC) – Member or Chair of Task Forces since 1986; Member of Scientific Committee since 2017

NC3Rs – Member of Regulatory Sciences Forum since 2024

British Toxicology Society – Member since 1982; Fellow since 2006; Member of Executive Committee since 2020, Vice-President 2022-2024, President 2024-2026

Society Of Toxicology – Member since 2009

Royal College of Pathologists – Fellow since 2001

Other personal interests.

My wife also works for Syngenta. (Since 1985)

Fellowships.

None.

Indirect support.

The British Toxicology Society receives donations from a number of companies (e.g. AstraZeneca, Corteva, GSK, Syngenta, Unilever, Apconix, Charles River, BIBRA) to support its activities, including an Annual Congress and Education and Training opportunities.

Trusteeships.

None.

Land and property.

None.

Other public appointments.

None.

Other non-personal interests.

None.

Direct employment.

None.

Consultancies and other fee-paid work.

None.

Shareholdings.

ICI 1980-1993. Zeneca 1993-1999 Syngenta 2001-2017

Clubs, other organisations and advocacy groups.

NC3Rs Board Member 2009-2014

ECVAM Scientific Advisory Committee Member 1993-2002

Advisory Committee on Pesticides Medical and Toxicological Panel 2005-2013

Other personal interests.

None.

Fellowships.

None.

Indirect support.

None.

Trusteeships.

None.

Land and property.

None.

Other public appointments.

None.

Other non-personal interests.

Direct employment.

None. 

Consultancies and other fee-paid work.

None. 

Shareholdings.

None. 

Clubs, other organisations and advocacy groups.

None. 

Other personal interests.

None. 

Fellowships.

None. 

Indirect support.

None. 

Trusteeships.

None. 

Land and property.

None. 

Other public appointments.

Wife is a member of the Food Standards Agency Advisory Committee on Animal Feedingstuffs (ACAF) and Science Council.  

Other non-personal interests.

None. 

Direct employment.

None. 

Consultancies and other fee-paid work.

Consultancy Nottingham Trent University (Silicon Supplement development), Silicon Active, my Wife is a  share holder.

Shareholdings.

None. 

Clubs, other organisations and advocacy groups.

None. 

Other personal interests.

None. 

Fellowships.

None. 

Indirect support.

None. 

Trusteeships.

None. 

Land and property.

None. 

Other public appointments.

None. 

Other non-personal interests.

Direct employment.

None. 

Consultancies and other fee-paid work.

Visiting Professor - University of Chester - 25 September 2017 – present.

Chair of the European Commission’s Scientific Committee on Consumer Safety (SCCS)  (Luxembourg), July 2009 – present:

The SCCS provides scientific advice to the EC on safety assessment of chemicals and nanomaterials in cosmetics and personal-care products; and publishes Guidance on risk assessment.

Member/ Chair of the WGs of European Food Safety Authority (EFSA) (Italy), July 2012 - present:

• Particle Risk Assessment (Chair)
• New Approach Methods (Member)
• Botanicals Compendium (Member)
• Guidance on Read-across (Member)

Member Food Standards Agency (FSA)'s Joint Expert Group on Additives, Enzymes and other Regulated Products, 05/2019 - present

Member Committee on Toxicity (COT), May 2025-present.

Shareholdings.

None. 

Clubs, other organisations and advocacy groups.

None. 

Other personal interests.

None. 

Fellowships.

Fellow of the Royal Society of Chemistry. 

Indirect support.

None. 

Trusteeships.

None. 

Land and property.

None. 

Other public appointments.

 None

Other non-personal interests.

Member, Italian Society of Toxicology (SITOX).
European Registered Toxicologist (ERT). 

Direct employment.

Professor of Food Safety & Innovation; University of 
Chester (Oct 2015 - Sep 2017),
Principle Scientist/ Advanced Research Fellow, The 
Food and Environment Research 
Agency, York (Dec 1990 - Sep 2015). 

Consultancies and other fee-paid work.

Member of the Office for Product Safety and Standards’ Scientific Advisory Group on Chemical Safety (SAG-CS) in Consumer Products, Apr 2021 – Jul 2023.

Expert Evaluator/ Project Technical Advisor for a few project proposals submitted to the European Commission under Horizon Europe, and Research Executive Agency. 09/2017 - ongoing

Project Technical Advisor for the European Commission to review progress of selected Horizon 2020 projects. Reviewer for the project proposals for the French National Research Agency (ANR) on Food packaging and containers and sustainability policies: new food constraints and impacts on nutrition and health – Alimentarité, 01/06/2024 - 31/08/2024.

Reviewer for the Office for Product Safety and Standards (OPSS), to steer research projects into investigating nanomaterials in complex matrices (toys) and volatile substances generated by consumer and construction products in indoor environment and their impact on indoor air quality, 01/05/2024 - 10/01/2025.  

Shareholdings.

None. 

Clubs, other organisations and advocacy groups.

None. 

Other personal interests.

None. 

Fellowships.

None. 

Indirect support.

None. 

Trusteeships.

None. 

Land and property.

None. 

Other public appointments.

None. 

Other non-personal interests.

Member Advisory Board of Horizon 2020 projects (NanoSolveIT: Innovative Nanoinformatics models and tools: towards a Solid, verified and Integrated Approach to Predictive (eco)Toxicology, and RiskGONE: Risk Governance of Nanotechnology, 01/2019 – to 12/2023 (non-remunerated position)

Direct employment.

Swansea University; Academic Position (Professor) (Since 2015)

Consultancies and other fee-paid work.

Titanium Dioxide Manufacturer’s Association (TDMA)/ Titanium Dioxide Industry Consultation (TDIC) (Since November 2023)

Huntsman Corporation (Expert scientist for particle toxicology) (Since Feb 2025)

Shareholdings.

None.

Clubs, other organisations and advocacy groups.

Chair of UK Animal Alternative Technologies (UKAAT), Since 2017

Journal Editor:

Editor-in-Chief; Fibres Fibers | An Open Access Journal from MDPI
Since 2018

Senior/Associate Editor:

Particle and Fibre Toxicology Home page | Particle and Fibre Toxicology Since 2022

Editorial Board member:
InVitro ModelsHome | In vitro models Since 2016

Other personal interests.

None.

Fellowships.

None. 

Indirect support.

None. 

Trusteeships.

None. 

Land and property.

None. 

Other public appointments.

COMEAP Member (since May 2021)

CAAP Member (since Sept 2024)

Other non-personal interests.

UKRI Medical Research Council (MRC) (co_investigator) (ca. £1.2 million) on Micronanoplastics (2025-2029).

UKRI Natural Environment Research Council (NERC) (co_investigator) (ca. £3.5 million) on indoor air pollution (2021-2026).COLT Foundation (charity) (Principal investigator) (ca. £300K) on micronanoplastics (2023-2026).

TDMA (industry) (Principal investigator) (ca. £450K) on TiO2 particle toxicology (2023-2026).

Huntsman (industry) (Principal) investigator) (ca. £45K) on human health assessment (2025-2026).

Direct employment.

Swansea University

(Academic Position; Professor) (Since December 2015).

Consultancies and other fee-paid work.

Expert scientist for particle toxicology (Since November 2023),

UKHSA – Solid Fuel Toxicology Review (February – April 2023),

Nooku – Toxicology Review on Health Effects of Indoor Air Pollution (February – March 2023).

Shareholdings.

None. 

Clubs, other organisations and advocacy groups.

Chair of UK Animal Alternative Technologies (UKAAT) (formerly the In Vitro Toxicology Society (IVTS) (Since October 2015),

Member of the British Toxicology Society (BTS) Sub-Scientific Committee (Since October 2017),

Member of Animal Free Research UK (February 2020 – June 2024),

Member of the British

Other personal interests.

None. 

Fellowships.

None. 

Indirect support.

None. 

Trusteeships.

None. 

Land and property.

None. 

Other public appointments.

None. 

Other non-personal interests.

Direct employment.

Cardiff University. (Since 2013)

Consultancies and other fee-paid work.

Director of Medical, Scientific & Toxicological Consultancy Ltd. (2016 - present)

Shareholdings.

Clubs, other organisations and advocacy groups.

National Trust. (2002 – present)

St John Ambulance Brigade, Wales. (2024 - present)

Other personal interests.

Honorary Professor Cardiff Metropolitan University (2018 – present.)

Fellowships.

Royal College of Physicians of London (2017- present), Royal College of Physicians of Edinburgh (2015 – present), British Pharmacology Society (2024 – present), Royal Society of Biology (2023 – present).  

Indirect support.

None.

Trusteeships.

None.

Land and property.

None.

Other public appointments.

None.

Other non-personal interests.

None.

Direct employment.

None.

Consultancies and other fee-paid work.

None.

Shareholdings.

None.

Clubs, other organisations and advocacy groups.

None.

Other personal interests.

None.

Fellowships.

None.

Indirect support.

None.

Trusteeships.

None.

Land and property.

None.

Other public appointments.

None.

Other non-personal interests.

Direct employment.

Ramboll UK Limited, since 2016

Consultancies and other fee-paid work.

Member of ACNFP and RISEPP.

Shareholdings.

None. 

Clubs, other organisations and advocacy groups.

Ramboll is a member of Food and Drink Federation (FDF) and I am the lead contact.

Other personal interests.

I work for clients who are food and food contact material manufacturers.

Visiting Lecturer at a University of Surrey, since 2013.

Visiting Researcher at University of Surrey between 2011 – 2014.

Visiting Lecturer at Kingston University between 2008 – 2009..

Fellowships.

None. 

Indirect support.

None. 

Trusteeships.

None. 

Land and property.

None. 

Other public appointments.

Member of COC, ACNFP and RISEP.

Other non-personal interests.

None. 

Direct employment.

Senior Toxicologist, Delphic HSE Solutions Limited 2013 – 2016

Toxicologist, Public Health England, 2008 – 2013

Investigator (Histology), ReNeuron Limited, 2007 – 2008

Mammalian Toxicologist, WRc plc, 2006 – 2007

Scientific Assistant (Microbiology), Veolia Water Partnership, 2000 - 2001 

Consultancies and other fee-paid work.

None. 

Shareholdings.

None. 

Clubs, other organisations and advocacy groups.

None. 

Other personal interests.

Co-author of a report on toxicological data for PFAS on behalf of the German Environment Agency, 2023.

Co-author of a chapter on food safety in a non-fiction science book on human nutrition with Oxford University Press, 2023.

Co-author of a chapter on Water and Public Health in a non-fiction science book on Environmental Public Health Science: A Handbook for Field Professionals with Oxford University Press, 2014.

Fellowships.

None. 

Indirect support.

None. 

Trusteeships.

None. 

Land and property.

None. 

Other public appointments.

None. 

Other non-personal interests.

Direct employment.

Liverpool John Moores University Since 2006

Reader in Computational Toxicology.

Consultancies and other fee-paid work.

Consultancy (on-going projects):

Crop Life Europe (2020 – present; total value: €200,000),

BASF (2025 – present; total value €25,000),

P&G (2025 – present; total value €25,000).

Shareholdings.

None. 

Clubs, other organisations and advocacy groups.

None. 

Other personal interests.

None. 

Fellowships.

None. 

Indirect support.

Funding (all whilst employed at Liverpool John Moores University)

2026 (8 months): Read-across for plant protection products - water treatment project. Value €40,000. Principal Investigator.

Trusteeships.

None. 

Land and property.

None. 

Other public appointments.

None. 

Other non-personal interests.

None. 

Direct employment.

2005-2006: Peakdale Molecular; 2004-2005: Cyprotex Ltd

Consultancies and other fee-paid work.

Regulatory Science Associates: 2024 for 6 months: £8,000,

BASF: 2020 for 12 months: €35,000.

Shareholdings.

None. 

Clubs, other organisations and advocacy groups.

None. 

Other personal interests.

None. 

Fellowships.

None. 

Indirect support.

Funding (all whilst employed at Liverpool John Moores University)

2025 (3 months): Read-across for genotoxicity – extension (CropLife Europe). Value €20,000. Principal Investigator

2024 (6 months): Read-across genotoxicity consultancy (BASF). Value €25,000. Principal Investigator.

2024 (3 months): Read-across consultancy (Regulatory Science Associates). Value £6,720. Principal Investigator.

2024 (24 months): Read-across for genotoxicity (CropLife Europe). Value €100,000. Principal Investigator.

2023 (48 months): QuantumTox (Horizon 2023). Value: €380,000. Co-Investigator.

2022 (14 months): Pesticide cancer QSAR. Value: €60,000. Co-Investigator.

2020 (48 months): ECPA pesticides (Crop Life Europe). Value: €100,000. Co-Investigator.

2020 (12 months): BASF pesticide mutagenicity. Value: €25,000. Co-Investigator.

2020 (60 months): RiskHunter (H2020). Value €500,000. Co-Investigator.

2018 (12 months): OECD QSAR Toolbox development contract (Laboratory Mathematical Chemistry). Value: €10,000. Principal investigator

2017 (60 months): eTranSafe (H2020 IMI). Value €500,000. Co-Investigator.

2017 (24 months): CE-ToxGPS (Cosmetics Europe). Value €300,000. Co-Investigator.

2017 (48 months): in3 (H2020 Marie Curie training network). Value €250,000. Co-Investigator.

2016 (18 months): Cancer Potency Database (CEFIC LRi). Value €55,000. Co-Investigator.

2015 (36 months): iPIE IMI (EU IMI). Value: €150,000. Co-Investigator.

2013: Winner of the 2013 LUSH prize. Value: £25,000.

2013 (36 months): Molecular shape in drug design (Medchemica – match-funded PhD). Value: £36,000. Co-Investigator

2013 (36 months): NanoPuzzles (FP7). Value: €200,000. Co-Investigator.

2012 (36 months): OECD framework contract (European Chemicals Agency, OECD). Value: €30,000. Co-Investigator.

. 

Trusteeships.

None. 

Land and property.

None. 

Other public appointments.

None. 

Other non-personal interests.